Financial News
Ligand Pharm (NQ: LGND )
103.82
+0.20
(+0.19%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Press Releases about Ligand Pharm
![](https://mms.businesswire.com/media/20240820748761/en/1990362/5/New_Ligand_Logo.jpg)
![](https://mms.businesswire.com/media/20240806965162/en/1990362/5/New_Ligand_Logo.jpg)
Ligand Reports Second Quarter 2024 Financial Results
August 06, 2024
Via Business Wire
![](https://mms.businesswire.com/media/20240723930890/en/1990362/5/New_Ligand_Logo.jpg)
![](https://www.marketbeat.com/logos/articles/med_20240709161607_5-best-short-term-stocks-to-consider-investing-in.jpg)
![](https://mms.businesswire.com/media/20240706652097/en/1990362/5/New_Ligand_Logo.jpg)
![](https://ml.globenewswire.com/media/ca940278-cc18-4a3f-93b7-d8a034c998c9/small/lifecore-corporate-logo-2c-png.png)
![](https://mms.businesswire.com/media/20240627518993/en/1990362/5/New_Ligand_Logo.jpg)
![](https://mms.businesswire.com/media/20240618130919/en/1990362/5/New_Ligand_Logo.jpg)
![](https://mms.businesswire.com/media/20240523216667/en/1990362/5/New_Ligand_Logo.jpg)
![](https://mms.businesswire.com/media/20240507633610/en/2123419/5/logo.jpg)
![](https://mms.businesswire.com/media/20240507973195/en/2122485/5/Ligand_full_color_logo_FINAL.jpg)
![](https://mms.businesswire.com/media/20240423025889/en/2106309/5/logo.jpg)
![](https://mms.businesswire.com/media/20240408525422/en/1990362/5/New_Ligand_Logo.jpg)
![](https://mms.businesswire.com/media/20240403857451/en/2087841/22/Scott_Plesha_CEO_Pelthos_Therapeutics.jpg)
![](https://mms.businesswire.com/media/20240305561022/en/1990362/5/New_Ligand_Logo.jpg)
![](https://mms.businesswire.com/media/20240304017350/en/1990362/5/New_Ligand_Logo.jpg)
![](https://mms.businesswire.com/media/20240227868201/en/1990362/5/New_Ligand_Logo.jpg)
Ligand Reports Fourth Quarter and Full Year 2023 Financial Results
February 27, 2024
Via Business Wire
![](https://mms.businesswire.com/media/20240222424618/en/1990362/5/New_Ligand_Logo.jpg)
![](https://mms.businesswire.com/media/20240215878741/en/1990362/5/New_Ligand_Logo.jpg)
![](https://mms.businesswire.com/media/20240213620099/en/1990362/5/New_Ligand_Logo.jpg)
![](https://mms.businesswire.com/media/20240201924216/en/1990362/5/New_Ligand_Logo.jpg)
![](https://mms.businesswire.com/media/20240105377376/en/1990356/5/New_Ligand_Logo.jpg)
![](https://mms.businesswire.com/media/20231212987229/en/1967452/5/New_Ligand_Logo.jpg)
![](https://mms.businesswire.com/media/20231206842106/en/346436/5/Ligand-Logo-Registered5.jpg)
![](https://ml.globenewswire.com/media/73795541-56ed-4418-88e6-64a98922589f/small/palvella-logo-png.png)
![](https://mms.businesswire.com/media/20231108320171/en/346436/5/Ligand-Logo-Registered5.jpg)
Ligand Reports Third Quarter 2023 Financial Results
November 08, 2023
Via Business Wire
![](https://mms.businesswire.com/media/20231101846503/en/346436/5/Ligand-Logo-Registered5.jpg)
Ligand Acquires Royalty on Sanofi’s TZIELD® for $20 Million
November 01, 2023
Via Business Wire
![](https://mms.businesswire.com/media/20231025648141/en/346436/5/Ligand-Logo-Registered5.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.